The potential effect of statins on rituximab immunotherapy
The potential effect of statins on rituximab immunotherapy
coa reductase inhibitors, rituximab, lymphoma, cell, in-vivo, therapeutic activity, lovastatin-induced apoptosis, lipid rafts, protein geranylgeranylation, anti-cd20 monoclonal-antibody, rheumatoid-arthritis
0356-0358
Cragg, Mark S.
ec97f80e-f3c8-49b7-a960-20dff648b78c
March 2008
Cragg, Mark S.
ec97f80e-f3c8-49b7-a960-20dff648b78c
Other
fetchObject.action_uri=info_doi%2F10.1371%2Fjournal.pmed.0050077&representation=PDF
- Version of Record
Available under License Other.
More information
Published date: March 2008
Keywords:
coa reductase inhibitors, rituximab, lymphoma, cell, in-vivo, therapeutic activity, lovastatin-induced apoptosis, lipid rafts, protein geranylgeranylation, anti-cd20 monoclonal-antibody, rheumatoid-arthritis
Identifiers
Local EPrints ID: 62713
URI: http://eprints.soton.ac.uk/id/eprint/62713
ISSN: 1549-1277
PURE UUID: c2fc8637-97da-4756-a702-1e075fbed588
Catalogue record
Date deposited: 22 Dec 2008
Last modified: 16 Mar 2024 02:58
Export record
Altmetrics
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics